Skip to main content
Expand main menu
Close main menu
Optum Frontier Therapies debuts in Las Vegas
Optum Frontier Therapies' flagship location will serve rare disease patients in all 50 states.
Sun Pharma, Cassiopea ink license, supply agreements for Winlevi
Sun Pharma will have the exclusive right to commercialize Winlevi in the United States and Canada, and Cassiopea will be the exclusive supplier of the product.
AllianceRx Walgreens Prime earns URAC reaccreditation for home delivery pharmacy
URAC’s full accreditation status means AllianceRx Walgreens Prime’s home delivery services are meeting industry-leading standards.
AllianceRx Walgreens Prime highlights financial assistance efforts
The company said it has connected eligible patients to more than $600 million in financial assistance in the past two years.
Zydus Cadila receives tentative FDA OK for generic Tagrisso
Zydus Cadila's osimertinib provides a generic treatment for lung cancer.
Foresee Pharmaceuticals receives FDA nod for Camcevi
Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer.
AllianceRx Walgreens Prime offering hard-to-find HIV medicines
The first once-monthly injectable, and oral anti-diarrheal are accessible for adults living with HIV-1.
Amber Specialty Pharmacy partners with MarkeTouch Media to enhance care coordination
With MarkeTouch Media’s TouchPoint Management solution, Amber Specialty Pharmacy saw improvements in patient adherence, patient experience, and overall satisfaction.
Amneal acquires Kashiv Specialty Pharmaceuticals
Through the acquisition of Kashiv Specialty Pharmaceuticals, Amneal has gained a pipeline of 505(b)2 branded products and complex generics.
Aveo intros oral renal cell carcinoma treatment Fotivda
The medication is an oral, next generation vascular endothelial growth factor tyrosine kinase inhibitor.
McKesson augments integrated pharmacy services for specialty clinics
McKesson’s health system clients will be offered VHRxS’ full suite of specialty pharmacy consulting services.
KemPharm gets FDA nod for Azstarys
KemPharm's Azstarys is a once-daily product for the treatment of ADHD in patients age 6 years old and older.
Study tracks adherence to MS therapies in pregnant women, impact on hospitalizations
A Walgreens study, in collaboration with AllianceRx Walgreens Prime showed that adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events and costs.
Q&A: How Walgreens is helping fight the HIV epidemic
Walgreens’ Brad McElya discusses the retailer's efforts to be a resource for patients living with HIV, as well as those who want to know their HIV status and/or get started on pre-exposure prophylaxis.